imesulide in COVID-19 infectio

Not Applicable

Recruiting

• Conditions: COVID-19 infection.; COVID-19; U07.2

• Registration Number: IRCT20200723048178N1
• Lead Sponsor: Shaheed zulfiqar ali medical university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

The participant is willing and able to give informed consent for participation in the study and agrees with the study protocol
Not previously diagnosed with COVID-19 infection or treated.
Adults = 12 years

Exclusion Criteria

The participant is allergic to any of the study group
Inability to be followed up for the trial period
Already taking an NSAID or Nimesulide
Participants with a contraindication to any of the drugs including Active bleeding, Recent Myocardial infarction (last three months), or Peptic ulcer disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percent change in the oxygen saturation, hospitalization, or death. Timepoint: 1 week. Method of measurement: Oxygen saturation is measured via pulse oximeter.